REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,685,528 | +199.9% | 205,402 | +189.8% | 0.00% | – |
| Q2 2023 | $1,895,666 | +44.6% | 70,866 | +17.1% | 0.00% | – |
| Q1 2023 | $1,310,820 | +106.9% | 60,518 | +127.6% | 0.00% | – |
| Q4 2022 | $633,445 | +19.5% | 26,593 | -1.2% | 0.00% | – |
| Q3 2022 | $530,000 | +17.8% | 26,922 | +16.6% | 0.00% | – |
| Q2 2022 | $450,000 | -23.2% | 23,085 | +0.6% | 0.00% | – |
| Q1 2022 | $586,000 | +2.3% | 22,939 | +0.9% | 0.00% | – |
| Q4 2021 | $573,000 | +5.5% | 22,733 | +15.1% | 0.00% | – |
| Q3 2021 | $543,000 | -27.6% | 19,749 | -16.4% | 0.00% | – |
| Q2 2021 | $750,000 | +80.7% | 23,622 | +160.9% | 0.00% | – |
| Q1 2021 | $415,000 | -38.9% | 9,054 | -47.2% | 0.00% | – |
| Q4 2020 | $679,000 | +30.3% | 17,153 | +4.1% | 0.00% | – |
| Q2 2020 | $521,000 | – | 16,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |